{"gene":"KCNB2","run_date":"2026-04-28T18:06:54","timeline":{"discoveries":[{"year":1996,"finding":"A novel beta subunit, mKvbeta4, specifically associates with Kv2.2 (CDRK) to enhance its expression level up to 6-fold without changing elementary conductance or kinetics. Chimeric channel experiments showed the C-terminal end of Kv2.2 is essential for mKvbeta4 sensitivity. mKvbeta4 acts as a chaperone-like factor to permit integration of more Kv2.2 channels at the plasma membrane, and does not affect the closely related Kv2.1.","method":"Xenopus oocyte coexpression, chimeric channel analysis, co-localization of transcripts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — heterologous expression with chimeric subunit mutagenesis, multiple orthogonal methods, single lab","pmids":["8824288"],"is_preprint":false},{"year":1998,"finding":"Kv2.2 was isolated from human and canine gastrointestinal smooth muscle and shown to mediate a slowly activating delayed rectifier K+ current (15 pS single channels) when expressed in Xenopus oocytes, inhibited by TEA (IC50 2.6 mM), 4-AP (IC50 1.5 mM), and quinine (IC50 13.7 µM), and insensitive to charybdotoxin, establishing it as a component of delayed rectifier current in GI smooth muscle.","method":"Xenopus oocyte expression, single-channel patch clamp, pharmacological characterization, RT-PCR","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in oocytes with electrophysiological characterization and mutagenesis-independent pharmacological profiling","pmids":["9612272"],"is_preprint":false},{"year":1999,"finding":"Angiotensin II inhibits Kv2.2 current via AT1 receptor signaling in hypothalamic/brainstem neurons. Coexpression of Kv2.2 with AT1 receptor in Xenopus oocytes confirmed AT1 receptor-mediated inhibition of Kv2.2 current, contributing to increased neuronal firing rate.","method":"Xenopus oocyte coexpression, whole-cell patch clamp, pharmacological dissection, RT-PCR, Western blot","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution in oocytes plus native neuron recordings, multiple orthogonal methods","pmids":["10024310"],"is_preprint":false},{"year":2004,"finding":"The proximal C-terminal domain (proxC) of Kv2.2 mediates developmental and subunit-specific regulation of voltage-gated K+ current density in Xenopus spinal neurons. Chimeric Kv2.1/Kv2.2 subunits showed that loss of proxC allows Kv2.2-like subunits to increase current density in mature neurons, identifying a novel function for this domain in developmental regulation of channel expression.","method":"Chimeric channel overexpression in Xenopus embryos, two-electrode voltage clamp, in vivo current-density measurements","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 1-2 — chimeric/domain-swap mutagenesis in vivo with functional readout","pmids":["15306626"],"is_preprint":false},{"year":2006,"finding":"Kv2.2 interacts specifically with syntaxin 1A but not with the syntaxin 1A/SNAP-25 complex, in contrast to Kv2.1 which interacts with both. This differential SNARE regulation is attributable to differences in the C-termini of Kv2.1 and Kv2.2. Kv2.2 is the dominant Kv channel in pancreatic alpha and delta cells, where it would regulate glucagon and somatostatin secretion.","method":"Two-electrode voltage clamp in Xenopus oocytes, immunohistochemistry, comparative electrophysiology","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — functional characterization in oocytes with multiple SNARE combinations, IHC for cell-type localization","pmids":["16754785"],"is_preprint":false},{"year":2008,"finding":"Kv2.2 is highly expressed at axon initial segments of MNTB neurons, where Hodgkin-Huxley modelling and current-clamp recordings showed it plays a minor role during single APs but assists recovery of Nav channels from inactivation by hyperpolarizing interspike potentials during repetitive high-frequency AP firing.","method":"Quantitative RT-PCR, immunofluorescence/confocal imaging, Western blot with Kv2.2 KO control, Hodgkin-Huxley modelling, whole-cell current clamp","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — direct localization to axon initial segments with functional consequence confirmed by modelling and KO validation","pmids":["18511484"],"is_preprint":false},{"year":2008,"finding":"In Xenopus laevis neurons, Kv2.2 protein localizes to long axonal-like processes (distinct from Kv2.1 which is somatodendritic) and co-localizes intracellularly with alpha-tubulin in association with neuronal tracts, establishing a subcellular distribution consistent with roles in axonal signaling.","method":"Immunodetection with Kv2.2-specific antibody (validated against Kv2.1), confocal imaging of cultured neurons and tissue sections","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein localization with antibody validation, single lab","pmids":["18680201"],"is_preprint":false},{"year":2010,"finding":"Kv2.2 is abundantly expressed in a large subpopulation (~60%) of GABAergic neurons in the magnocellular preoptic nucleus and horizontal limb of the diagonal band of Broca of the basal forebrain, identified using GFP-knockin GABAergic reporter mice and specific immunolabeling.","method":"Immunolabeling, knockin GFP reporter mice (GABAergic neurons), confocal imaging","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with genetic reporter validation, single lab","pmids":["20853508"],"is_preprint":false},{"year":2012,"finding":"Kv2.2 specifically regulates somatostatin secretion in pancreatic delta cells, while Kv2.1 regulates insulin secretion in beta cells. adenovirus-shRNA knockdown of Kv2.2 in mouse islets selectively enhanced somatostatin but not insulin secretion, and pharmacological inhibition of Kv2 channels (guangxitoxin-1E) enhanced somatostatin release in Kv2.1-/- islets.","method":"Adenovirus-shRNA knockdown in mouse islets, selective pharmacological inhibitors, Kv2.1 KO mice, islet perifusion","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 2 — genetic KD plus pharmacology in KO background, multiple orthogonal methods","pmids":["23161216"],"is_preprint":false},{"year":2013,"finding":"In VNTB brainstem neurons of the medial olivocochlear system, Kv2.2 maintains short action potentials and enables high-frequency firing. Dominant-negative Kv2.2 viral gene transfer and Kv2.2 KO mice both showed increased AP half-width and reduced repetitive firing. In vivo, Kv2.2 KO mice were more susceptible to noise-induced hearing loss, demonstrating that Kv2.2 is required for efferent auditory protection.","method":"Viral dominant-negative gene transfer, Kv2.2 KO mice, whole-cell patch clamp, in vivo auditory brainstem response recordings","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — convergent evidence from dominant-negative and KO with in vivo physiological readout","pmids":["23699522"],"is_preprint":false},{"year":2013,"finding":"miR-1 directly targets KCNB2 (confirmed by luciferase assay) and downregulates its expression in atrial tachypacing, contributing to shortening of the atrial effective refractory period. siRNA knockdown of KCNB2 alone was sufficient to shorten AERP and increase IKs in atrial cells.","method":"Luciferase reporter assay, siRNA knockdown, lentiviral miR-1 overexpression, whole-cell patch clamp, in vivo rabbit model","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — direct target validation by luciferase assay plus functional electrophysiology, multiple orthogonal methods","pmids":["24386485"],"is_preprint":false},{"year":2013,"finding":"Pyruvate-isocitrate cycling (via ICDc) regulates Kv2.2 expression in pancreatic beta-cells. Kv2.2 acts as a negative regulator of total Kv channel activity through physical interaction with Kv2.1 (demonstrated by immunoprecipitation); co-overexpression of Kv2.1 and Kv2.2 reduced outward K+ current compared with Kv2.1 alone. ICDc knockdown phenocopied Kv2.2 knockdown in impairing GSIS, and was rescued by Kv2.2 re-expression.","method":"siRNA knockdown, immunoprecipitation (Kv2.1-Kv2.2 interaction), selective Kv2.1 inhibitor stromatoxin-1, rescue by re-expression, GSIS assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — Co-IP interaction plus genetic epistasis (rescue) plus pharmacology, multiple orthogonal methods","pmids":["23788641"],"is_preprint":false},{"year":2013,"finding":"Kv2.2-expressing basal forebrain GABAergic neurons regulate the sleep-wake cycle. Kv2.2 KO mice showed longer consolidated wake bouts, decreased delta-frequency EEG during NREM sleep, and augmented c-Fos in BF GABAergic neurons, indicating Kv2.2-expressing neurons are active during wakefulness and their dysfunction prolongs waking.","method":"EEG/EMG recordings, Kv2.2 KO mice, c-Fos immunostaining, sleep deprivation protocol","journal":"Sleep","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with defined electrophysiological and behavioral phenotype, multiple readouts","pmids":["24293758"],"is_preprint":false},{"year":2018,"finding":"Kv2.2 is expressed in Fañanas cells (a distinct astrocytic subtype) of the cerebellar Purkinje cell layer, identified as a marker protein using antibody-based immunocytochemistry.","method":"Immunocytochemistry with multiple labeling methods, confocal imaging","journal":"Glia","confidence":"Low","confidence_rationale":"Tier 3 — localization only, no functional consequence established","pmids":["30151916"],"is_preprint":false},{"year":2021,"finding":"PKC phosphorylates Kv2.2 at S481 and S488, inhibiting Kv2.2 currents and shifting steady-state activation, thereby reducing action potential firing frequency in cortical layer II pyramidal neurons. Point mutations at these residues abolished PKC-dependent modulation.","method":"PKC activation in HEK293 cells and cortical slices, point mutagenesis, phospho-specific antibodies, whole-cell patch clamp, current clamp in brain slices","journal":"Neuroscience bulletin","confidence":"High","confidence_rationale":"Tier 1-2 — point mutagenesis identifying phosphorylation sites, confirmed in native neurons, multiple orthogonal methods","pmids":["34542799"],"is_preprint":false},{"year":2021,"finding":"An inter-subunit hydrogen bond formed by W366 and Y376 (Kv2.1 numbering; conserved in Kv2.2) is essential for K+ conductance; mutations breaking this bond result in complete loss of K+ conductance in Kv2.1, Kv2.2, and Kv1.2 channels, distinct from the W434-D447/T439-Y445 bonds controlling slow inactivation in Shaker.","method":"Point mutagenesis, patch-clamp recording in mammalian expression system","journal":"Membranes","confidence":"Medium","confidence_rationale":"Tier 1 — mutagenesis with functional readout, single lab","pmids":["33803465"],"is_preprint":false},{"year":2021,"finding":"EZH2-mediated H3K27me3 represses KCNB2 expression in bladder smooth muscle cells during obstruction; EZH2 inhibition restored Kv2.2 expression and partially restored smooth muscle cell phenotype, placing Kv2.2 downstream of EZH2 epigenetic regulation in a disease context.","method":"ChIP/PCR for H3K27me3 at KCNB2 promoter, EZH2 inhibitor (UNC1999), siRNA against KCNB2, Western blot, immunostaining, RT-qPCR","journal":"American journal of clinical and experimental urology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP demonstrating epigenetic mark at locus plus pharmacological and siRNA functional validation","pmids":["37645613"],"is_preprint":false},{"year":2023,"finding":"Glucocorticoids (cortisol) rapidly activate Kv2.2 channels via membrane-associated glucocorticoid receptors and ERK1/2 kinase signaling (non-genomic), increasing single-channel open probability. This suppresses action potential firing frequency in cortical pyramidal neurons and calyx of Held synapses and increases activity-dependent synaptic depression. BSA-conjugated dexamethasone (membrane-impermeable) mimicked the effect; U0126 (ERK inhibitor) blocked it.","method":"Single-channel recording, HEK293 cell overexpression, acute cortical and brainstem slices, membrane-impermeable agonist, ERK inhibitor, patch clamp","journal":"Neurobiology of stress","confidence":"High","confidence_rationale":"Tier 1-2 — single-channel evidence, membrane-impermeable agonist control, pathway inhibitor, multiple cell-type validation","pmids":["38075025"],"is_preprint":false},{"year":2025,"finding":"PGE2 inhibits Kv2.2 channels via PKA-dependent phosphorylation at S448 through EP2/4 receptors, reducing action potential firing in pancreatic beta-cells and impairing glucose-stimulated insulin secretion (GSIS). Kcnb2 knockout mice showed reduced GSIS and were resistant to PGE2-induced glucose intolerance, confirming the EP2/4-Kv2.2 pathway as the mechanistic basis for PGE2 inhibition of GSIS.","method":"Point mutagenesis (S448), HEK293T overexpression, EP receptor agonists/antagonists, siRNA knockdown in INS-1 cells, Kcnb2 KO mice, glucose tolerance test, islet perifusion, patch clamp","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — phosphorylation site identified by mutagenesis, validated in native beta-cells and KO mice with multiple orthogonal methods","pmids":["40028769"],"is_preprint":false},{"year":2025,"finding":"Kv2.2 subunits co-cluster with Kv2.1 and Kv6.4 at ER-plasma membrane junctions beneath C-bouton synapses in spinal motor neurons. Clustering of Kv6.4 (and AMIGO-1) was severely reduced in Kv2.1 KO and moderately reduced in Kv2.2 KO mice, indicating Kv6.4 localization depends on co-assembly with Kv2 subunits. In Kv2.1 S590A mice (unable to bind ER VAP proteins), Kv2.1 and Kv6.4 clustering at ER-PM junctions was severely reduced.","method":"Immunofluorescence co-localization, Kv2.1 KO and Kv2.2 KO mice, Kv2.1 S590A knock-in mice, confocal imaging","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — co-localization with genetic KO/KI validation, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.06.04.657913"],"is_preprint":true}],"current_model":"KCNB2 (Kv2.2) encodes a voltage-gated delayed-rectifier K+ channel whose functional expression is enhanced by the mKvbeta4 chaperone subunit via its C-terminal domain; the channel is regulated by PKC-mediated phosphorylation at S481/S488 and PKA-mediated phosphorylation at S448 (downstream of PGE2-EP2/4 and glucocorticoid-ERK1/2 signaling), interacts physically with Kv2.1 to negatively regulate total Kv current in beta-cells, is regulated epigenetically by EZH2/H3K27me3 at its promoter, forms heteromeric complexes with Kv6.4 at ER-PM junctions in motor neurons, mediates AT1-receptor-dependent neuronal K+ current inhibition, supports high-frequency firing in auditory brainstem neurons by hyperpolarizing interspike intervals, controls somatostatin secretion in pancreatic delta cells, regulates the sleep-wake cycle through basal forebrain GABAergic neurons, and is directly targeted and downregulated by miR-1 to shorten atrial effective refractory periods."},"narrative":{"teleology":[{"year":1996,"claim":"Identifying how Kv2.2 reaches the cell surface revealed that the accessory subunit mKvβ4 acts as a chaperone that increases Kv2.2 membrane expression up to 6-fold through the channel's C-terminal domain, establishing the first known regulatory mechanism for Kv2.2 surface density.","evidence":"Xenopus oocyte coexpression with chimeric channel analysis","pmids":["8824288"],"confidence":"High","gaps":["Whether mKvβ4 acts on Kv2.2 trafficking in native neurons was not tested","Structural basis of C-terminus/mKvβ4 interaction unresolved"]},{"year":1998,"claim":"Cloning Kv2.2 from gastrointestinal smooth muscle and reconstituting its current in oocytes defined its biophysical identity as a slowly activating delayed rectifier (~15 pS) with a distinctive pharmacological profile (TEA-sensitive, charybdotoxin-insensitive), placing it as a contributor to delayed-rectifier currents outside the nervous system.","evidence":"Xenopus oocyte expression, single-channel patch clamp, pharmacological profiling","pmids":["9612272"],"confidence":"High","gaps":["Relative contribution versus other Kv channels in native GI smooth muscle not quantified"]},{"year":1999,"claim":"Demonstrating that angiotensin II inhibits Kv2.2 current through the AT1 receptor in hypothalamic/brainstem neurons established the first GPCR-to-Kv2.2 signaling axis, linking the channel to cardiovascular autonomic regulation.","evidence":"Xenopus oocyte coexpression of Kv2.2 with AT1R plus native neuron recordings","pmids":["10024310"],"confidence":"High","gaps":["Downstream second messengers mediating AT1R-to-Kv2.2 inhibition not identified","Phosphorylation site not mapped"]},{"year":2004,"claim":"Chimeric subunit experiments in Xenopus spinal neurons showed that the proximal C-terminal domain of Kv2.2 gates developmental regulation of Kv current density, distinguishing Kv2.2 from Kv2.1 in developmental channel scaling.","evidence":"Chimeric Kv2.1/Kv2.2 overexpression in Xenopus embryos with in vivo voltage clamp","pmids":["15306626"],"confidence":"High","gaps":["Molecular interactors of the proxC domain remain unknown","Mammalian validation not performed"]},{"year":2006,"claim":"Showing that Kv2.2 interacts with syntaxin 1A but not the syntaxin 1A/SNAP-25 complex (unlike Kv2.1) revealed SNARE-selectivity differences between the two Kv2 paralogs and identified Kv2.2 as the dominant Kv channel in islet alpha and delta cells, predicting roles in glucagon and somatostatin secretion.","evidence":"Oocyte electrophysiology with SNARE coexpression, immunohistochemistry of pancreatic islets","pmids":["16754785"],"confidence":"High","gaps":["Direct functional consequence of syntaxin 1A interaction on Kv2.2 gating in native cells not shown"]},{"year":2008,"claim":"Localization of Kv2.2 to the axon initial segment of MNTB auditory neurons and to axonal processes in Xenopus cultured neurons established its subcellular compartmentalization, with modeling showing it aids Nav channel recovery during high-frequency firing.","evidence":"Immunofluorescence with KO-validated antibodies, Hodgkin-Huxley modeling, confocal imaging","pmids":["18511484","18680201"],"confidence":"High","gaps":["Whether axonal targeting signals reside in Kv2.2 sequence elements was not mapped"]},{"year":2012,"claim":"shRNA knockdown of Kv2.2 in islets selectively enhanced somatostatin but not insulin secretion, while a parallel study showed Kv2.2 physically interacts with Kv2.1 in beta cells to negatively regulate total Kv current and GSIS, delineating cell-type-specific roles for the two Kv2 paralogs in islet hormone secretion.","evidence":"Adenovirus-shRNA knockdown, Kv2.1 KO islets with guangxitoxin-1E, co-immunoprecipitation, rescue experiments","pmids":["23161216","23788641"],"confidence":"High","gaps":["Stoichiometry of Kv2.1/Kv2.2 heteromers in native beta cells undetermined","Whether Kv2.2 forms homomeric channels in delta cells versus heteromers not resolved"]},{"year":2013,"claim":"Kv2.2 knockout mice demonstrated two major physiological roles: in auditory brainstem neurons, loss of Kv2.2 broadened APs and impaired high-frequency firing, increasing susceptibility to noise-induced hearing loss; in basal forebrain GABAergic neurons, loss prolonged consolidated wakefulness and reduced NREM delta power, establishing Kv2.2 in sleep–wake regulation.","evidence":"Kv2.2 KO mice with viral dominant-negative, ABR recordings, EEG/EMG sleep analysis, c-Fos immunostaining","pmids":["23699522","24293758"],"confidence":"High","gaps":["Compensatory upregulation of other channels in KO not assessed","Circuit-level mechanism linking BF GABAergic activity to wake consolidation not delineated"]},{"year":2013,"claim":"Identification of KCNB2 as a direct target of miR-1 in atrial tachypacing-induced remodeling showed that miR-1-mediated downregulation of Kv2.2 shortens the atrial effective refractory period and increases IKs, linking the channel to atrial fibrillation substrate.","evidence":"Luciferase reporter assay, siRNA knockdown, lentiviral miR-1 overexpression, rabbit tachypacing model, patch clamp","pmids":["24386485"],"confidence":"High","gaps":["Whether Kv2.2 restoration prevents AF in vivo not tested","Relative contribution of Kv2.2 versus other miR-1 targets to AERP shortening unclear"]},{"year":2021,"claim":"Mapping PKC phosphorylation sites to S481 and S488 on Kv2.2 showed that phosphorylation inhibits channel current and shifts activation, reducing firing frequency in cortical pyramidal neurons — the first direct phosphosite identification for Kv2.2 regulation of cortical excitability.","evidence":"Point mutagenesis, phospho-specific antibodies, patch clamp in HEK293 cells and acute cortical slices","pmids":["34542799"],"confidence":"High","gaps":["Upstream activators of PKC targeting Kv2.2 in cortex not identified","Whether S481/S488 phosphorylation is constitutive or stimulus-dependent in vivo unknown"]},{"year":2021,"claim":"Demonstrating that EZH2-mediated H3K27me3 silences KCNB2 at its promoter in obstructed bladder smooth muscle placed Kv2.2 under epigenetic control and showed that EZH2 inhibition restores Kv2.2 expression, linking channel repression to smooth muscle pathology.","evidence":"ChIP-PCR for H3K27me3 at KCNB2 promoter, EZH2 inhibitor, siRNA knockdown, Western blot","pmids":["37645613"],"confidence":"Medium","gaps":["Whether H3K27me3-mediated regulation of Kv2.2 occurs in other tissues not explored","Functional electrophysiological consequence in bladder smooth muscle not recorded"]},{"year":2023,"claim":"Glucocorticoids rapidly activate Kv2.2 via membrane-associated glucocorticoid receptors and ERK1/2 signaling (non-genomic), increasing single-channel open probability and suppressing neuronal firing, revealing a stress-hormone pathway that tunes Kv2.2 activity within seconds.","evidence":"Single-channel recording, membrane-impermeable BSA-dexamethasone, ERK inhibitor U0126, cortical and brainstem slices","pmids":["38075025"],"confidence":"High","gaps":["Specific phosphorylation site(s) mediating ERK1/2 activation of Kv2.2 not mapped","Whether this pathway operates in non-neuronal tissues unknown"]},{"year":2025,"claim":"PGE2 was shown to inhibit Kv2.2 through EP2/4-PKA-dependent phosphorylation at S448, suppressing beta-cell firing and GSIS; Kcnb2 KO mice were resistant to PGE2-induced glucose intolerance, establishing the complete receptor-to-channel signaling axis for prostaglandin-mediated insulin secretion impairment.","evidence":"S448 point mutagenesis, EP receptor agonists/antagonists, Kcnb2 KO mice, glucose tolerance tests, islet perifusion, patch clamp","pmids":["40028769"],"confidence":"High","gaps":["Whether S448 phosphorylation intersects with PKC-mediated S481/S488 phosphorylation not tested","Role of Kv2.2 in inflammatory settings where PGE2 is elevated not examined in vivo"]},{"year":null,"claim":"Major open questions include the high-resolution structure of Kv2.2, the full phosphorylation landscape integrating PKA, PKC, and ERK inputs, the stoichiometry and functional properties of native Kv2.1/Kv2.2 and Kv2.2/Kv6.4 heteromers, and the mechanisms governing Kv2.2's axonal versus somatic targeting in different neuronal populations.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of Kv2.2 available","Phosphosite cross-talk between PKA, PKC, and ERK not mapped","Native heteromer stoichiometry unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,2,5,9,14,17,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,5,6,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[19]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,5,9,12,14,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,14,17,18]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,5,9,14,18]}],"complexes":[],"partners":["KCNB1","KCNAB3","STX1A","KCNG4"],"other_free_text":[]},"mechanistic_narrative":"KCNB2 (Kv2.2) encodes a voltage-gated delayed-rectifier potassium channel that shapes neuronal excitability, endocrine secretion, and cardiac repolarization across diverse tissues. The channel conducts a slowly activating delayed-rectifier K+ current (~15 pS), is enhanced at the plasma membrane by the chaperone subunit mKvβ4 via its C-terminal domain, and is functionally tuned by PKC phosphorylation at S481/S488 (inhibiting current and shifting activation), PKA phosphorylation at S448 (downstream of PGE2-EP2/4 signaling), and non-genomic glucocorticoid-ERK1/2 signaling that increases open probability [PMID:8824288, PMID:34542799, PMID:40028769, PMID:38075025]. In the nervous system, Kv2.2 localizes to axon initial segments and supports high-frequency firing in auditory brainstem neurons, with Kv2.2 knockout mice showing broader action potentials, impaired repetitive firing, and increased susceptibility to noise-induced hearing loss; in basal forebrain GABAergic neurons it regulates the sleep–wake cycle, as knockout prolongs consolidated wakefulness [PMID:23699522, PMID:24293758]. In pancreatic islets, Kv2.2 is the dominant Kv channel in delta cells where it controls somatostatin secretion, physically interacts with Kv2.1 in beta cells to negatively regulate total Kv current and glucose-stimulated insulin secretion, and mediates PGE2-induced suppression of insulin release through EP2/4-PKA-dependent phosphorylation at S448 [PMID:23161216, PMID:23788641, PMID:40028769]."},"prefetch_data":{"uniprot":{"accession":"Q92953","full_name":"Potassium voltage-gated channel subfamily B member 2","aliases":["Voltage-gated potassium channel subunit Kv2.2"],"length_aa":911,"mass_kda":102.6,"function":"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and smooth muscle cells. Channels open or close in response to the voltage difference across the membrane, letting potassium ions pass in accordance with their electrochemical gradient. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization. Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNB1; channel properties depend on the type of alpha subunits that are part of the channel. Can also form functional heterotetrameric channels with other alpha subunits that are non-conducting when expressed alone, such as KCNS1 and KCNS2, creating a functionally diverse range of channel complexes. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Contributes to the delayed-rectifier voltage-gated potassium current in cortical pyramidal neurons and smooth muscle cells","subcellular_location":"Cell membrane; Perikaryon; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/Q92953/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNB2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNB2","total_profiled":1310},"omim":[{"mim_id":"613382","title":"BRACHYDACTYLY, TYPE E2; BDE2","url":"https://www.omim.org/entry/613382"},{"mim_id":"608164","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1; KCNV1","url":"https://www.omim.org/entry/608164"},{"mim_id":"607738","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2","url":"https://www.omim.org/entry/607738"},{"mim_id":"168470","title":"PARATHYROID HORMONE-LIKE HORMONE; PTHLH","url":"https://www.omim.org/entry/168470"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Midbody","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":2.0},{"tissue":"lymphoid tissue","ntpm":2.2},{"tissue":"retina","ntpm":4.2}],"url":"https://www.proteinatlas.org/search/KCNB2"},"hgnc":{"alias_symbol":["Kv2.2"],"prev_symbol":[]},"alphafold":{"accession":"Q92953","domains":[{"cath_id":"3.30.710.10","chopping":"25-132","consensus_level":"medium","plddt":91.6538,"start":25,"end":132},{"cath_id":"1.20.120,1.20.120","chopping":"166-317","consensus_level":"high","plddt":86.8161,"start":166,"end":317},{"cath_id":"1.10.287.70","chopping":"330-439","consensus_level":"high","plddt":92.4173,"start":330,"end":439}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92953","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92953-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92953-F1-predicted_aligned_error_v6.png","plddt_mean":60.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNB2","jax_strain_url":"https://www.jax.org/strain/search?query=KCNB2"},"sequence":{"accession":"Q92953","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92953.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92953/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92953"}},"corpus_meta":[{"pmid":"18511484","id":"PMC_18511484","title":"Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons.","date":"2008","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18511484","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8824288","id":"PMC_8824288","title":"A new K+ channel beta subunit to specifically enhance Kv2.2 (CDRK) expression.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8824288","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24386485","id":"PMC_24386485","title":"MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24386485","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23161216","id":"PMC_23161216","title":"The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.","date":"2012","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23161216","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20853508","id":"PMC_20853508","title":"Immunolocalization of the voltage-gated potassium channel Kv2.2 in GABAergic neurons in the basal forebrain of rats and mice.","date":"2010","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20853508","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10024310","id":"PMC_10024310","title":"Angiotensin II type 1 receptor-mediated inhibition of K+ channel subunit kv2.2 in brain stem and hypothalamic neurons.","date":"1999","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10024310","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23699522","id":"PMC_23699522","title":"Protection from noise-induced hearing loss by Kv2.2 potassium currents in the central medial olivocochlear system.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23699522","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24293758","id":"PMC_24293758","title":"Kv2.2: a novel molecular target to study the role of basal forebrain GABAergic neurons in the sleep-wake cycle.","date":"2013","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/24293758","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23788641","id":"PMC_23788641","title":"Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23788641","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16754785","id":"PMC_16754785","title":"Target soluble N-ethylmaleimide-sensitive factor attachment protein receptors (t-SNAREs) differently regulate activation and inactivation gating of Kv2.2 and Kv2.1: Implications on pancreatic islet cell Kv channels.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16754785","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30151916","id":"PMC_30151916","title":"Fañanas cells-the forgotten cerebellar glia cell type: Immunocytochemistry reveals two potassium channel-related polypeptides, Kv2.2 and Calsenilin (KChIP3) as potential marker proteins.","date":"2018","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/30151916","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27033450","id":"PMC_27033450","title":"The contribution of Kv2.2-mediated currents decreases during the postnatal development of mouse dorsal root ganglion neurons.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27033450","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34542799","id":"PMC_34542799","title":"Protein Kinase C Controls the Excitability of Cortical Pyramidal Neurons by Regulating Kv2.2 Channel Activity.","date":"2021","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/34542799","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12399537","id":"PMC_12399537","title":"The Kv2.2 alpha subunit contributes to delayed rectifier K(+) currents in myocytes from rabbit corpus cavernosum.","date":"2002","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/12399537","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18680201","id":"PMC_18680201","title":"Localization of Kv2.2 protein in Xenopus laevis embryos and tadpoles.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18680201","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15306626","id":"PMC_15306626","title":"Carboxyl tail region of the Kv2.2 subunit mediates novel developmental regulation of channel density.","date":"2004","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/15306626","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33803465","id":"PMC_33803465","title":"Regulation of K+ Conductance by a Hydrogen Bond in Kv2.1, Kv2.2, and Kv1.2 Channels.","date":"2021","source":"Membranes","url":"https://pubmed.ncbi.nlm.nih.gov/33803465","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38075025","id":"PMC_38075025","title":"Glucocorticoids modulate neural activity via a rapid non-genomic effect on Kv2.2 channels in the central nervous system.","date":"2023","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/38075025","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39577484","id":"PMC_39577484","title":"The KCNB2 gene and its role in neurodevelopmental disorders: Implications for genetics and therapeutic advances.","date":"2024","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39577484","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40028769","id":"PMC_40028769","title":"The Kv2.2 channel mediates the inhibition of prostaglandin E2 on glucose-stimulated insulin secretion in pancreatic β-cells.","date":"2025","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/40028769","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37645613","id":"PMC_37645613","title":"EZH2 and matrix co-regulate phenotype and KCNB2 expression in bladder smooth muscle cells.","date":"2023","source":"American journal of clinical and experimental urology","url":"https://pubmed.ncbi.nlm.nih.gov/37645613","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40494277","id":"PMC_40494277","title":"Taking the \"lazy\" way identifies KCNB2 as a regulator of SHH-MB maintenance.","date":"2025","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/40494277","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.04.657913","title":"Kv2/Kv6.4 heteromeric potassium channels are expressed in spinal motor neurons and localized at C-bouton synapses","date":"2025-06-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.04.657913","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16382104","id":"PMC_16382104","title":"International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.","date":"2005","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16382104","citation_count":721,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19010793","id":"PMC_19010793","title":"Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19010793","citation_count":366,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22412388","id":"PMC_22412388","title":"A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22412388","citation_count":117,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33124732","id":"PMC_33124732","title":"FFAT motif phosphorylation controls formation and lipid transfer function of inter-organelle contacts.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33124732","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8670833","id":"PMC_8670833","title":"Kv8.1, a new neuronal potassium channel subunit with specific inhibitory properties towards Shab and Shaw channels.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8670833","citation_count":109,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34709727","id":"PMC_34709727","title":"SARS-CoV-2-host proteome interactions for antiviral drug discovery.","date":"2021","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/34709727","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14988243","id":"PMC_14988243","title":"Expression of voltage-gated potassium channels in human and rhesus pancreatic islets.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14988243","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17903301","id":"PMC_17903301","title":"Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.","date":"2007","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17903301","citation_count":82,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31663850","id":"PMC_31663850","title":"Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31663850","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20125193","id":"PMC_20125193","title":"Common genetic variation and performance on standardized cognitive tests.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20125193","citation_count":78,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18676988","id":"PMC_18676988","title":"A high-density association screen of 155 ion transport genes for involvement with common migraine.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18676988","citation_count":72,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17474147","id":"PMC_17474147","title":"Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.","date":"2007","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/17474147","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25339316","id":"PMC_25339316","title":"Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25339316","citation_count":56,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9612272","id":"PMC_9612272","title":"Molecular identification of a component of delayed rectifier current in gastrointestinal smooth muscles.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9612272","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28607108","id":"PMC_28607108","title":"Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28607108","citation_count":38,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36950384","id":"PMC_36950384","title":"Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.","date":"2023","source":"Cell genomics","url":"https://pubmed.ncbi.nlm.nih.gov/36950384","citation_count":38,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23953852","id":"PMC_23953852","title":"Genome-wide association studies of maximum number of drinks.","date":"2013","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/23953852","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34702444","id":"PMC_34702444","title":"RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34702444","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27619418","id":"PMC_27619418","title":"Pore size matters for potassium channel conductance.","date":"2016","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27619418","citation_count":29,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32393512","id":"PMC_32393512","title":"SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32393512","citation_count":27,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19074135","id":"PMC_19074135","title":"Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19074135","citation_count":18,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22422395","id":"PMC_22422395","title":"Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22422395","citation_count":17,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32062451","id":"PMC_32062451","title":"PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32062451","citation_count":17,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13833,"output_tokens":4444,"usd":0.05408},"stage2":{"model":"claude-opus-4-6","input_tokens":7904,"output_tokens":3123,"usd":0.176393},"total_usd":0.517366,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":28132,"output_tokens":5244,"usd":0.081528},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8992,"output_tokens":3678,"usd":0.205365}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"A novel beta subunit, mKvbeta4, specifically associates with Kv2.2 (CDRK) to enhance its expression level up to 6-fold without changing elementary conductance or kinetics; chimeras between Kv2.1 and Kv2.2 showed the C-terminal end of Kv2.2 is essential for mKvbeta4 sensitivity, suggesting a chaperone-like effect allowing more channels at the plasma membrane.\",\n      \"method\": \"Xenopus oocyte co-expression, chimeric subunit analysis, co-localization of transcripts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — heterologous expression with chimeric mutagenesis identifying C-terminus as essential domain, replicated with multiple constructs\",\n      \"pmids\": [\"8824288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Angiotensin II, acting through AT1 receptors, inhibits Kv2.2 currents in hypothalamic/brainstem neurons; co-expression of Kv2.2 and AT1 receptor in Xenopus oocytes confirmed Ang II-induced inhibition of Kv2.2 current, contributing to increased neuronal firing rate.\",\n      \"method\": \"Whole-cell patch clamp, Western blot, RT-PCR, Xenopus oocyte co-expression, pharmacological dissection\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — heterologous reconstitution in oocytes plus native neuronal recordings with pharmacological and molecular confirmation\",\n      \"pmids\": [\"10024310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The proximal C-terminal domain (proxC) of Kv2.2 mediates a developmental and subunit-specific regulation of channel density in maturing Xenopus spinal neurons; chimeric Kv2 subunits lacking proxC increased current density even in mature neurons, whereas full-length Kv2.2 did not.\",\n      \"method\": \"In vivo chimeric subunit overexpression in Xenopus embryos, two-electrode voltage clamp\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chimeric mutagenesis with functional readout in vivo, single lab\",\n      \"pmids\": [\"15306626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Kv2.2 interacts with syntaxin 1A but, in contrast to Kv2.1, does not interact with the syntaxin 1A/SNAP-25 complex and is insensitive to the assembly/disassembly state of this complex; this differential regulation is attributed to differences in their C-termini and is relevant to distinct secretory regulation in pancreatic islet alpha and delta cells.\",\n      \"method\": \"Two-electrode voltage clamp in oocytes, immunohistochemistry, comparative functional analysis with Kv2.1 chimeras\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — heterologous expression with functional comparison and channel-SNARE interaction characterized, single lab\",\n      \"pmids\": [\"16754785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kv2.2 channels are highly expressed at the axon initial segment of MNTB neurons and regulate high-frequency action potential firing by hyperpolarizing interspike potentials to assist recovery of Nav channels from inactivation; Hodgkin-Huxley modeling and current-clamp recordings confirmed this functional role.\",\n      \"method\": \"Quantitative RT-PCR, Western blot (confirmed with Kv2.2 KO mouse), confocal immunofluorescence, patch clamp, Hodgkin-Huxley modeling\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KO validation and computational modeling, replicated by functional electrophysiology\",\n      \"pmids\": [\"18511484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kv2.2 protein localizes to long axonal-like processes in neurons and is associated intracellularly with alpha-tubulin, contrasting with Kv2.1 which does not localize to axons; an antibody specific for Kv2.2 (not cross-reacting with Kv2.1) was validated.\",\n      \"method\": \"Immunofluorescence with subunit-specific antibody, live imaging of cultured Xenopus neurons\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization experiment with functional implication, single lab, ortholog (Xenopus)\",\n      \"pmids\": [\"18680201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kv2.2 is abundantly expressed in a large subpopulation of GABAergic neurons in the magnocellular preoptic nucleus and horizontal limb of the diagonal band of Broca of the basal forebrain, as determined by specific immunolabeling and GFP-knockin GABAergic reporter mice.\",\n      \"method\": \"Immunolabeling, GFP-knockin reporter mice for GABAergic neurons, confocal imaging\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific antibody validated, GABAergic reporter knockin mice used, direct localization\",\n      \"pmids\": [\"20853508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Kv2.2 specifically modulates somatostatin release from pancreatic delta cells, while Kv2.1 regulates insulin secretion from beta cells; adenovirus-shRNA silencing of Kv2.2 in mouse islets selectively enhanced somatostatin but not insulin secretion.\",\n      \"method\": \"Kv2.1 KO mouse, adenovirus-shRNA knockdown, selective pharmacological inhibitors (GxTX-1E, RY796), in situ perfused pancreata, patch clamp\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus specific shRNA knockdown with defined secretory phenotype, multiple methods in multiple systems\",\n      \"pmids\": [\"23161216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Kv2.2 regulates neuronal excitability in VNTB neurons by maintaining short action potentials and enabling high-frequency firing; dominant-negative Kv2.2 viral gene transfer suppressed outward K+ currents and increased AP half-width, and Kv2.2 KO mice showed increased AP duration and greater susceptibility to noise-induced hearing loss.\",\n      \"method\": \"Dominant-negative viral gene transfer, Kv2.2 KO mouse, whole-cell patch clamp, in vivo auditory brainstem response recordings\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus dominant-negative approach with multiple functional readouts in vitro and in vivo\",\n      \"pmids\": [\"23699522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"miR-1 targets KCNB2 (Kv2.2) and KCNE1 as direct target genes, downregulating their expression; this contributes to shortening of atrial effective refractory period and increased IKs in atrial tachypacing; luciferase activity assay confirmed miR-1 direct targeting of KCNB2.\",\n      \"method\": \"Luciferase reporter assay, lentiviral miR-1 overexpression, siRNA knockdown, qRT-PCR, Western blot, whole-cell patch clamp\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase assay confirming direct targeting, functional rescue experiments, but limited to rabbit model\",\n      \"pmids\": [\"24386485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Kv2.2 expression in pancreatic islet beta-cells is controlled by the pyruvate-isocitrate cycling pathway via ICDc; Kv2.1 and Kv2.2 physically interact (co-immunoprecipitation), and Kv2.2 acts as a negative regulator of total Kv channel activity—its knockdown paradoxically increases outward K+ current, and co-overexpression of Kv2.1 and Kv2.2 reduces outward K+ current compared to Kv2.1 alone.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation, whole-cell patch clamp in 832/13 β-cells, rescue by Kv2.2 re-expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP demonstrating Kv2.1-Kv2.2 interaction plus functional epistasis with siRNA rescue, single lab\",\n      \"pmids\": [\"23788641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Kv2.2-expressing basal forebrain GABAergic neurons regulate the sleep-wake cycle; Kv2.2 KO mice exhibit longer consolidated wake bouts and decreased delta-frequency EEG activity during NREM sleep, and Kv2.2-expressing neurons show preferential c-Fos activation during wakefulness.\",\n      \"method\": \"EEG/EMG recordings, Kv2.2 KO mouse, c-Fos immunostaining, sleep deprivation protocol\",\n      \"journal\": \"Sleep\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined behavioral and EEG phenotype plus c-Fos activity marker\",\n      \"pmids\": [\"24293758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PKC phosphorylates Kv2.2 at residues S481 and S488, inhibiting Kv2.2 currents and shifting steady-state activation; this PKC-dependent modulation reduces action potential firing frequency in layer II cortical pyramidal neurons.\",\n      \"method\": \"Point mutation analysis, phospho-specific antibodies, patch clamp in HEK293 cells and cortical slices, PKC activators/inhibitors\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — site-directed mutagenesis identifying specific phosphorylation residues, validated in native neurons with functional readout\",\n      \"pmids\": [\"34542799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"An inter-subunit hydrogen bond formed by W366 and Y376 (Kv2.1 numbering, conserved in Kv2.2) is essential for K+ conductance; mutations breaking this bond result in complete loss of K+ conductance in Kv2.2 channels.\",\n      \"method\": \"Point mutagenesis, patch-clamp recording in HEK cells\",\n      \"journal\": \"Membranes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with clear loss-of-function conductance phenotype, single lab single method\",\n      \"pmids\": [\"33803465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Glucocorticoids (cortisol) rapidly activate Kv2.2 channels through membrane-associated glucocorticoid receptors via the ERK1/2 signaling pathway, increasing single-channel open probability; this non-genomic effect suppresses cortical pyramidal neuron action potential firing and inhibits presynaptic high-frequency synaptic transmission at calyx of Held synapses.\",\n      \"method\": \"Single-channel recording, whole-cell patch clamp in HEK293 and acute brain slices, membrane-impermeable GR agonist (BSA-dexamethasone), ERK1/2 inhibitor (U0126), Kv2.2 KO validation\",\n      \"journal\": \"Neurobiology of stress\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — single-channel recordings plus multiple pharmacological approaches and membrane-impermeable agonist to establish non-genomic mechanism\",\n      \"pmids\": [\"38075025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"EZH2-mediated H3K27me3 histone modification at the KCNB2 promoter represses KCNB2 expression in bladder smooth muscle cells; EZH2 inhibition restores KCNB2 expression and partially restores SMC phenotype, and matrix context co-regulates this epigenetic control.\",\n      \"method\": \"ChIP/PCR, immunostaining, Western blot, siRNA knockdown, EZH2 inhibitor (UNC1999)\",\n      \"journal\": \"American journal of clinical and experimental urology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming H3K27me3 at KCNB2 promoter plus pharmacological rescue, single lab\",\n      \"pmids\": [\"37645613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PGE2 inhibits Kv2.2 channels in pancreatic beta-cells via EP2/4 receptor activation and PKA-dependent phosphorylation at S448; this EP2/4-Kv2.2 signaling pathway mediates PGE2 inhibition of glucose-stimulated insulin secretion, confirmed by Kcnb2 KO mice which abrogated PGE2 effects on GSIS.\",\n      \"method\": \"Point mutation analysis, Kv2.2 KO mouse, siRNA knockdown in INS-1 cells, patch clamp, immunofluorescence, glucose tolerance tests\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis identifying specific PKA site, KO mouse rescue experiment, multiple cell systems tested\",\n      \"pmids\": [\"40028769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In spinal motor neurons, Kv2.2 co-clusters with Kv2.1 and Kv6.4 at endoplasmic reticulum-plasma membrane junctions beneath C-bouton synapses; Kv6.4 clustering is moderately reduced in Kv2.2 KO mice, indicating Kv2.2 supports Kv6.4 localization through co-assembly into heteromeric channels.\",\n      \"method\": \"Immunofluorescence co-clustering, Kv2.1 S590A knockin mice, Kv2.1 and Kv2.2 KO mice, Western blot\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and knockin mouse models with direct co-localization, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.04.657913\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"KCNB2 (Kv2.2) encodes a voltage-gated delayed rectifier K+ channel that localizes preferentially to axon initial segments and ER-plasma membrane junctions, forms heteromeric complexes with Kv2.1 and silent KvS subunits (e.g., Kv6.4), and is regulated by multiple post-translational mechanisms including PKC phosphorylation at S481/S488, PKA phosphorylation at S448, ERK1/2-mediated glucocorticoid signaling, and interaction with the beta subunit mKvbeta4 (which enhances surface expression via its C-terminus) and SNARE proteins (syntaxin 1A only, not the syntaxin/SNAP-25 complex); functionally, Kv2.2 regulates neuronal excitability to support high-frequency firing in brainstem auditory nuclei and cortical neurons, controls somatostatin secretion from pancreatic delta cells, mediates PGE2 inhibition of insulin secretion in beta cells, and regulates sleep-wake cycling through basal forebrain GABAergic neurons.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"A novel beta subunit, mKvbeta4, specifically associates with Kv2.2 (CDRK) to enhance its expression level up to 6-fold without changing elementary conductance or kinetics. Chimeric channel experiments showed the C-terminal end of Kv2.2 is essential for mKvbeta4 sensitivity. mKvbeta4 acts as a chaperone-like factor to permit integration of more Kv2.2 channels at the plasma membrane, and does not affect the closely related Kv2.1.\",\n      \"method\": \"Xenopus oocyte coexpression, chimeric channel analysis, co-localization of transcripts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — heterologous expression with chimeric subunit mutagenesis, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"8824288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Kv2.2 was isolated from human and canine gastrointestinal smooth muscle and shown to mediate a slowly activating delayed rectifier K+ current (15 pS single channels) when expressed in Xenopus oocytes, inhibited by TEA (IC50 2.6 mM), 4-AP (IC50 1.5 mM), and quinine (IC50 13.7 µM), and insensitive to charybdotoxin, establishing it as a component of delayed rectifier current in GI smooth muscle.\",\n      \"method\": \"Xenopus oocyte expression, single-channel patch clamp, pharmacological characterization, RT-PCR\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in oocytes with electrophysiological characterization and mutagenesis-independent pharmacological profiling\",\n      \"pmids\": [\"9612272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Angiotensin II inhibits Kv2.2 current via AT1 receptor signaling in hypothalamic/brainstem neurons. Coexpression of Kv2.2 with AT1 receptor in Xenopus oocytes confirmed AT1 receptor-mediated inhibition of Kv2.2 current, contributing to increased neuronal firing rate.\",\n      \"method\": \"Xenopus oocyte coexpression, whole-cell patch clamp, pharmacological dissection, RT-PCR, Western blot\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution in oocytes plus native neuron recordings, multiple orthogonal methods\",\n      \"pmids\": [\"10024310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The proximal C-terminal domain (proxC) of Kv2.2 mediates developmental and subunit-specific regulation of voltage-gated K+ current density in Xenopus spinal neurons. Chimeric Kv2.1/Kv2.2 subunits showed that loss of proxC allows Kv2.2-like subunits to increase current density in mature neurons, identifying a novel function for this domain in developmental regulation of channel expression.\",\n      \"method\": \"Chimeric channel overexpression in Xenopus embryos, two-electrode voltage clamp, in vivo current-density measurements\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — chimeric/domain-swap mutagenesis in vivo with functional readout\",\n      \"pmids\": [\"15306626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Kv2.2 interacts specifically with syntaxin 1A but not with the syntaxin 1A/SNAP-25 complex, in contrast to Kv2.1 which interacts with both. This differential SNARE regulation is attributable to differences in the C-termini of Kv2.1 and Kv2.2. Kv2.2 is the dominant Kv channel in pancreatic alpha and delta cells, where it would regulate glucagon and somatostatin secretion.\",\n      \"method\": \"Two-electrode voltage clamp in Xenopus oocytes, immunohistochemistry, comparative electrophysiology\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional characterization in oocytes with multiple SNARE combinations, IHC for cell-type localization\",\n      \"pmids\": [\"16754785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kv2.2 is highly expressed at axon initial segments of MNTB neurons, where Hodgkin-Huxley modelling and current-clamp recordings showed it plays a minor role during single APs but assists recovery of Nav channels from inactivation by hyperpolarizing interspike potentials during repetitive high-frequency AP firing.\",\n      \"method\": \"Quantitative RT-PCR, immunofluorescence/confocal imaging, Western blot with Kv2.2 KO control, Hodgkin-Huxley modelling, whole-cell current clamp\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization to axon initial segments with functional consequence confirmed by modelling and KO validation\",\n      \"pmids\": [\"18511484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In Xenopus laevis neurons, Kv2.2 protein localizes to long axonal-like processes (distinct from Kv2.1 which is somatodendritic) and co-localizes intracellularly with alpha-tubulin in association with neuronal tracts, establishing a subcellular distribution consistent with roles in axonal signaling.\",\n      \"method\": \"Immunodetection with Kv2.2-specific antibody (validated against Kv2.1), confocal imaging of cultured neurons and tissue sections\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization with antibody validation, single lab\",\n      \"pmids\": [\"18680201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kv2.2 is abundantly expressed in a large subpopulation (~60%) of GABAergic neurons in the magnocellular preoptic nucleus and horizontal limb of the diagonal band of Broca of the basal forebrain, identified using GFP-knockin GABAergic reporter mice and specific immunolabeling.\",\n      \"method\": \"Immunolabeling, knockin GFP reporter mice (GABAergic neurons), confocal imaging\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with genetic reporter validation, single lab\",\n      \"pmids\": [\"20853508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Kv2.2 specifically regulates somatostatin secretion in pancreatic delta cells, while Kv2.1 regulates insulin secretion in beta cells. adenovirus-shRNA knockdown of Kv2.2 in mouse islets selectively enhanced somatostatin but not insulin secretion, and pharmacological inhibition of Kv2 channels (guangxitoxin-1E) enhanced somatostatin release in Kv2.1-/- islets.\",\n      \"method\": \"Adenovirus-shRNA knockdown in mouse islets, selective pharmacological inhibitors, Kv2.1 KO mice, islet perifusion\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KD plus pharmacology in KO background, multiple orthogonal methods\",\n      \"pmids\": [\"23161216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In VNTB brainstem neurons of the medial olivocochlear system, Kv2.2 maintains short action potentials and enables high-frequency firing. Dominant-negative Kv2.2 viral gene transfer and Kv2.2 KO mice both showed increased AP half-width and reduced repetitive firing. In vivo, Kv2.2 KO mice were more susceptible to noise-induced hearing loss, demonstrating that Kv2.2 is required for efferent auditory protection.\",\n      \"method\": \"Viral dominant-negative gene transfer, Kv2.2 KO mice, whole-cell patch clamp, in vivo auditory brainstem response recordings\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — convergent evidence from dominant-negative and KO with in vivo physiological readout\",\n      \"pmids\": [\"23699522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"miR-1 directly targets KCNB2 (confirmed by luciferase assay) and downregulates its expression in atrial tachypacing, contributing to shortening of the atrial effective refractory period. siRNA knockdown of KCNB2 alone was sufficient to shorten AERP and increase IKs in atrial cells.\",\n      \"method\": \"Luciferase reporter assay, siRNA knockdown, lentiviral miR-1 overexpression, whole-cell patch clamp, in vivo rabbit model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct target validation by luciferase assay plus functional electrophysiology, multiple orthogonal methods\",\n      \"pmids\": [\"24386485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pyruvate-isocitrate cycling (via ICDc) regulates Kv2.2 expression in pancreatic beta-cells. Kv2.2 acts as a negative regulator of total Kv channel activity through physical interaction with Kv2.1 (demonstrated by immunoprecipitation); co-overexpression of Kv2.1 and Kv2.2 reduced outward K+ current compared with Kv2.1 alone. ICDc knockdown phenocopied Kv2.2 knockdown in impairing GSIS, and was rescued by Kv2.2 re-expression.\",\n      \"method\": \"siRNA knockdown, immunoprecipitation (Kv2.1-Kv2.2 interaction), selective Kv2.1 inhibitor stromatoxin-1, rescue by re-expression, GSIS assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP interaction plus genetic epistasis (rescue) plus pharmacology, multiple orthogonal methods\",\n      \"pmids\": [\"23788641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Kv2.2-expressing basal forebrain GABAergic neurons regulate the sleep-wake cycle. Kv2.2 KO mice showed longer consolidated wake bouts, decreased delta-frequency EEG during NREM sleep, and augmented c-Fos in BF GABAergic neurons, indicating Kv2.2-expressing neurons are active during wakefulness and their dysfunction prolongs waking.\",\n      \"method\": \"EEG/EMG recordings, Kv2.2 KO mice, c-Fos immunostaining, sleep deprivation protocol\",\n      \"journal\": \"Sleep\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined electrophysiological and behavioral phenotype, multiple readouts\",\n      \"pmids\": [\"24293758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kv2.2 is expressed in Fañanas cells (a distinct astrocytic subtype) of the cerebellar Purkinje cell layer, identified as a marker protein using antibody-based immunocytochemistry.\",\n      \"method\": \"Immunocytochemistry with multiple labeling methods, confocal imaging\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization only, no functional consequence established\",\n      \"pmids\": [\"30151916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PKC phosphorylates Kv2.2 at S481 and S488, inhibiting Kv2.2 currents and shifting steady-state activation, thereby reducing action potential firing frequency in cortical layer II pyramidal neurons. Point mutations at these residues abolished PKC-dependent modulation.\",\n      \"method\": \"PKC activation in HEK293 cells and cortical slices, point mutagenesis, phospho-specific antibodies, whole-cell patch clamp, current clamp in brain slices\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — point mutagenesis identifying phosphorylation sites, confirmed in native neurons, multiple orthogonal methods\",\n      \"pmids\": [\"34542799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"An inter-subunit hydrogen bond formed by W366 and Y376 (Kv2.1 numbering; conserved in Kv2.2) is essential for K+ conductance; mutations breaking this bond result in complete loss of K+ conductance in Kv2.1, Kv2.2, and Kv1.2 channels, distinct from the W434-D447/T439-Y445 bonds controlling slow inactivation in Shaker.\",\n      \"method\": \"Point mutagenesis, patch-clamp recording in mammalian expression system\",\n      \"journal\": \"Membranes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with functional readout, single lab\",\n      \"pmids\": [\"33803465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EZH2-mediated H3K27me3 represses KCNB2 expression in bladder smooth muscle cells during obstruction; EZH2 inhibition restored Kv2.2 expression and partially restored smooth muscle cell phenotype, placing Kv2.2 downstream of EZH2 epigenetic regulation in a disease context.\",\n      \"method\": \"ChIP/PCR for H3K27me3 at KCNB2 promoter, EZH2 inhibitor (UNC1999), siRNA against KCNB2, Western blot, immunostaining, RT-qPCR\",\n      \"journal\": \"American journal of clinical and experimental urology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating epigenetic mark at locus plus pharmacological and siRNA functional validation\",\n      \"pmids\": [\"37645613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Glucocorticoids (cortisol) rapidly activate Kv2.2 channels via membrane-associated glucocorticoid receptors and ERK1/2 kinase signaling (non-genomic), increasing single-channel open probability. This suppresses action potential firing frequency in cortical pyramidal neurons and calyx of Held synapses and increases activity-dependent synaptic depression. BSA-conjugated dexamethasone (membrane-impermeable) mimicked the effect; U0126 (ERK inhibitor) blocked it.\",\n      \"method\": \"Single-channel recording, HEK293 cell overexpression, acute cortical and brainstem slices, membrane-impermeable agonist, ERK inhibitor, patch clamp\",\n      \"journal\": \"Neurobiology of stress\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — single-channel evidence, membrane-impermeable agonist control, pathway inhibitor, multiple cell-type validation\",\n      \"pmids\": [\"38075025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PGE2 inhibits Kv2.2 channels via PKA-dependent phosphorylation at S448 through EP2/4 receptors, reducing action potential firing in pancreatic beta-cells and impairing glucose-stimulated insulin secretion (GSIS). Kcnb2 knockout mice showed reduced GSIS and were resistant to PGE2-induced glucose intolerance, confirming the EP2/4-Kv2.2 pathway as the mechanistic basis for PGE2 inhibition of GSIS.\",\n      \"method\": \"Point mutagenesis (S448), HEK293T overexpression, EP receptor agonists/antagonists, siRNA knockdown in INS-1 cells, Kcnb2 KO mice, glucose tolerance test, islet perifusion, patch clamp\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phosphorylation site identified by mutagenesis, validated in native beta-cells and KO mice with multiple orthogonal methods\",\n      \"pmids\": [\"40028769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Kv2.2 subunits co-cluster with Kv2.1 and Kv6.4 at ER-plasma membrane junctions beneath C-bouton synapses in spinal motor neurons. Clustering of Kv6.4 (and AMIGO-1) was severely reduced in Kv2.1 KO and moderately reduced in Kv2.2 KO mice, indicating Kv6.4 localization depends on co-assembly with Kv2 subunits. In Kv2.1 S590A mice (unable to bind ER VAP proteins), Kv2.1 and Kv6.4 clustering at ER-PM junctions was severely reduced.\",\n      \"method\": \"Immunofluorescence co-localization, Kv2.1 KO and Kv2.2 KO mice, Kv2.1 S590A knock-in mice, confocal imaging\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-localization with genetic KO/KI validation, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.04.657913\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"KCNB2 (Kv2.2) encodes a voltage-gated delayed-rectifier K+ channel whose functional expression is enhanced by the mKvbeta4 chaperone subunit via its C-terminal domain; the channel is regulated by PKC-mediated phosphorylation at S481/S488 and PKA-mediated phosphorylation at S448 (downstream of PGE2-EP2/4 and glucocorticoid-ERK1/2 signaling), interacts physically with Kv2.1 to negatively regulate total Kv current in beta-cells, is regulated epigenetically by EZH2/H3K27me3 at its promoter, forms heteromeric complexes with Kv6.4 at ER-PM junctions in motor neurons, mediates AT1-receptor-dependent neuronal K+ current inhibition, supports high-frequency firing in auditory brainstem neurons by hyperpolarizing interspike intervals, controls somatostatin secretion in pancreatic delta cells, regulates the sleep-wake cycle through basal forebrain GABAergic neurons, and is directly targeted and downregulated by miR-1 to shorten atrial effective refractory periods.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNB2 (Kv2.2) encodes a voltage-gated delayed rectifier potassium channel that regulates neuronal excitability, endocrine secretion, and sleep-wake behavior by shaping action potential waveform and firing frequency across multiple cell types. In auditory brainstem neurons, Kv2.2 localizes to the axon initial segment where it hyperpolarizes interspike potentials to support high-frequency firing, and loss of Kv2.2 broadens action potentials and increases susceptibility to noise-induced hearing loss [PMID:18511484, PMID:23699522]. Kv2.2 forms heteromeric complexes with Kv2.1 and silent modifier subunits such as Kv6.4, and acts as a negative regulator of total Kv current when co-assembled with Kv2.1; its activity is inhibited by PKC phosphorylation at S481/S488 and by PKA phosphorylation at S448, and is activated non-genomically by glucocorticoids via the ERK1/2 pathway [PMID:23788641, PMID:34542799, PMID:40028769, PMID:38075025]. In pancreatic islets, Kv2.2 selectively controls somatostatin secretion from delta cells and mediates PGE2 inhibition of glucose-stimulated insulin secretion from beta cells through EP2/4-PKA-dependent channel inhibition [PMID:23161216, PMID:40028769].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"The discovery that the beta subunit mKvβ4 specifically enhances Kv2.2 surface expression through its C-terminus established that Kv2.2 channel density is regulated by accessory subunit-dependent trafficking, not by changes in single-channel conductance.\",\n      \"evidence\": \"Xenopus oocyte co-expression with chimeric subunit analysis identifying the C-terminal domain as required for mKvβ4 sensitivity\",\n      \"pmids\": [\"8824288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the C-terminal binding interface on Kv2.2 for mKvβ4 not mapped at residue level\", \"Whether mKvβ4 acts similarly in mammalian neurons not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Angiotensin II was shown to inhibit Kv2.2 currents via AT1 receptors, establishing that Kv2.2 is subject to GPCR-mediated modulation relevant to sympathetic neuronal excitability.\",\n      \"evidence\": \"Whole-cell patch clamp in hypothalamic/brainstem neurons and reconstitution in Xenopus oocytes with AT1 receptor co-expression\",\n      \"pmids\": [\"10024310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling cascade between AT1 receptor and Kv2.2 not identified\", \"Phosphorylation site mediating Ang II inhibition unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The proximal C-terminal domain of Kv2.2 was identified as a developmental regulator of channel density, explaining why Kv2.2 current density is constrained during neuronal maturation even as the channel is expressed.\",\n      \"evidence\": \"In vivo chimeric subunit overexpression in Xenopus embryonic spinal neurons with voltage clamp\",\n      \"pmids\": [\"15306626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding partners of the proxC domain that restrict channel density not identified\", \"Whether this developmental regulation operates in mammalian neurons remains untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Kv2.2 was found to interact with syntaxin 1A but not the syntaxin 1A/SNAP-25 complex, differentiating it from Kv2.1 and implying distinct roles in coupling channel activity to exocytotic machinery in endocrine cells.\",\n      \"evidence\": \"Two-electrode voltage clamp in oocytes with Kv2.1/Kv2.2 chimeras, immunohistochemistry in pancreatic islets\",\n      \"pmids\": [\"16754785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for selective syntaxin 1A interaction not resolved\", \"Functional consequence of the syntaxin interaction for delta-cell secretion not directly demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Kv2.2 was localized to the axon initial segment of auditory brainstem MNTB neurons and shown to be essential for high-frequency firing by enabling Nav channel recovery from inactivation, establishing its primary physiological role in fast-spiking neurons.\",\n      \"evidence\": \"KO mouse validation, confocal immunofluorescence, patch clamp, Hodgkin-Huxley modeling; axonal localization confirmed in Xenopus neurons with subunit-specific antibody\",\n      \"pmids\": [\"18511484\", \"18680201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism targeting Kv2.2 to the AIS versus somatodendritic domain not defined\", \"Whether Kv2.2 AIS localization is universal across neuron types not established\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Kv2.2 was assigned a cell-type-specific secretory role in pancreatic islets: it selectively regulates somatostatin release from delta cells, while Kv2.1 controls insulin secretion from beta cells.\",\n      \"evidence\": \"Kv2.1 KO mouse, adenovirus-shRNA Kv2.2 knockdown, selective pharmacological inhibitors, perfused pancreas hormone secretion assays\",\n      \"pmids\": [\"23161216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for delta-cell-specific expression of Kv2.2 unknown\", \"Whether Kv2.2 also regulates glucagon secretion from alpha cells not fully excluded\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Multiple studies converged to show that Kv2.2 physically interacts with Kv2.1 to form heteromeric channels that negatively regulate total Kv current, Kv2.2 KO mice have altered sleep-wake architecture with longer wake bouts, and Kv2.2 loss broadens action potentials and increases noise-induced hearing loss susceptibility — collectively demonstrating diverse physiological consequences of Kv2.2 function.\",\n      \"evidence\": \"Co-immunoprecipitation of Kv2.1–Kv2.2; Kv2.2 KO mouse with EEG/EMG sleep recordings and c-Fos mapping; dominant-negative viral gene transfer with auditory brainstem response in vivo\",\n      \"pmids\": [\"23788641\", \"24293758\", \"23699522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Kv2.1/Kv2.2 heteromers not determined\", \"How Kv2.2-expressing basal forebrain neurons connect to sleep-promoting circuits not mapped\", \"Whether heteromeric assembly is required for the sleep phenotype unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"PKC-dependent phosphorylation at S481 and S488 was identified as a mechanism that inhibits Kv2.2 currents and reduces cortical pyramidal neuron firing frequency, and a conserved inter-subunit hydrogen bond (W366–Y376) was shown essential for K+ conductance, advancing structural and regulatory understanding of the channel.\",\n      \"evidence\": \"Site-directed mutagenesis with phospho-specific antibodies, patch clamp in HEK293 and cortical slices; separate point mutagenesis in HEK cells for conductance studies\",\n      \"pmids\": [\"34542799\", \"33803465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S481/S488 phosphorylation occurs in vivo under physiological stimulation not confirmed\", \"Full post-translational modification map of Kv2.2 not yet established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Glucocorticoids were shown to rapidly activate Kv2.2 through membrane-associated glucocorticoid receptors and ERK1/2 signaling, establishing a non-genomic pathway that suppresses neuronal firing and high-frequency synaptic transmission.\",\n      \"evidence\": \"Single-channel recordings, membrane-impermeable GR agonist, ERK1/2 inhibitor, Kv2.2 KO validation in cortical slices and calyx of Held\",\n      \"pmids\": [\"38075025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ERK1/2 phosphorylation site on Kv2.2 not identified\", \"Whether this non-genomic pathway operates in non-neuronal Kv2.2-expressing cells unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PGE2 was found to inhibit Kv2.2 via EP2/4 receptors and PKA phosphorylation at S448, mediating PGE2 suppression of glucose-stimulated insulin secretion in beta cells — linking an inflammatory mediator to Kv2.2-dependent metabolic regulation.\",\n      \"evidence\": \"S448 point mutation analysis, Kcnb2 KO mouse abrogating PGE2 effects on GSIS, siRNA knockdown in INS-1 cells, glucose tolerance tests\",\n      \"pmids\": [\"40028769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S448 phosphorylation by PKA also modulates Kv2.2 in neurons not tested\", \"Interplay between PKC (S481/S488) and PKA (S448) phosphorylation on channel function not examined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the high-resolution structure of Kv2.2, the stoichiometry and functional properties of Kv2.1/Kv2.2/KvS heteromers, the molecular targeting mechanism to the axon initial segment, and whether Kv2.2 non-conducting functions at ER-PM junctions contribute to its physiological roles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or X-ray structure of Kv2.2 published\", \"Heteromeric channel stoichiometry and gating properties not determined\", \"AIS targeting motif not identified\", \"Non-conducting roles at ER-PM junctions not functionally tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 4, 7, 8, 12, 14, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 5, 17]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 4, 8, 11, 12, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 14, 16]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 4, 7, 8, 12, 16]}\n    ],\n    \"complexes\": [\n      \"Kv2.1/Kv2.2 heteromeric channel\",\n      \"Kv2.2/Kv6.4 heteromeric channel\"\n    ],\n    \"partners\": [\n      \"KCNB1\",\n      \"KCNG4\",\n      \"STX1A\",\n      \"KCNMB4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"KCNB2 (Kv2.2) encodes a voltage-gated delayed-rectifier potassium channel that shapes neuronal excitability, endocrine secretion, and cardiac repolarization across diverse tissues. The channel conducts a slowly activating delayed-rectifier K+ current (~15 pS), is enhanced at the plasma membrane by the chaperone subunit mKvβ4 via its C-terminal domain, and is functionally tuned by PKC phosphorylation at S481/S488 (inhibiting current and shifting activation), PKA phosphorylation at S448 (downstream of PGE2-EP2/4 signaling), and non-genomic glucocorticoid-ERK1/2 signaling that increases open probability [PMID:8824288, PMID:34542799, PMID:40028769, PMID:38075025]. In the nervous system, Kv2.2 localizes to axon initial segments and supports high-frequency firing in auditory brainstem neurons, with Kv2.2 knockout mice showing broader action potentials, impaired repetitive firing, and increased susceptibility to noise-induced hearing loss; in basal forebrain GABAergic neurons it regulates the sleep–wake cycle, as knockout prolongs consolidated wakefulness [PMID:23699522, PMID:24293758]. In pancreatic islets, Kv2.2 is the dominant Kv channel in delta cells where it controls somatostatin secretion, physically interacts with Kv2.1 in beta cells to negatively regulate total Kv current and glucose-stimulated insulin secretion, and mediates PGE2-induced suppression of insulin release through EP2/4-PKA-dependent phosphorylation at S448 [PMID:23161216, PMID:23788641, PMID:40028769].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identifying how Kv2.2 reaches the cell surface revealed that the accessory subunit mKvβ4 acts as a chaperone that increases Kv2.2 membrane expression up to 6-fold through the channel's C-terminal domain, establishing the first known regulatory mechanism for Kv2.2 surface density.\",\n      \"evidence\": \"Xenopus oocyte coexpression with chimeric channel analysis\",\n      \"pmids\": [\"8824288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mKvβ4 acts on Kv2.2 trafficking in native neurons was not tested\", \"Structural basis of C-terminus/mKvβ4 interaction unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Cloning Kv2.2 from gastrointestinal smooth muscle and reconstituting its current in oocytes defined its biophysical identity as a slowly activating delayed rectifier (~15 pS) with a distinctive pharmacological profile (TEA-sensitive, charybdotoxin-insensitive), placing it as a contributor to delayed-rectifier currents outside the nervous system.\",\n      \"evidence\": \"Xenopus oocyte expression, single-channel patch clamp, pharmacological profiling\",\n      \"pmids\": [\"9612272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution versus other Kv channels in native GI smooth muscle not quantified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that angiotensin II inhibits Kv2.2 current through the AT1 receptor in hypothalamic/brainstem neurons established the first GPCR-to-Kv2.2 signaling axis, linking the channel to cardiovascular autonomic regulation.\",\n      \"evidence\": \"Xenopus oocyte coexpression of Kv2.2 with AT1R plus native neuron recordings\",\n      \"pmids\": [\"10024310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream second messengers mediating AT1R-to-Kv2.2 inhibition not identified\", \"Phosphorylation site not mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Chimeric subunit experiments in Xenopus spinal neurons showed that the proximal C-terminal domain of Kv2.2 gates developmental regulation of Kv current density, distinguishing Kv2.2 from Kv2.1 in developmental channel scaling.\",\n      \"evidence\": \"Chimeric Kv2.1/Kv2.2 overexpression in Xenopus embryos with in vivo voltage clamp\",\n      \"pmids\": [\"15306626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular interactors of the proxC domain remain unknown\", \"Mammalian validation not performed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that Kv2.2 interacts with syntaxin 1A but not the syntaxin 1A/SNAP-25 complex (unlike Kv2.1) revealed SNARE-selectivity differences between the two Kv2 paralogs and identified Kv2.2 as the dominant Kv channel in islet alpha and delta cells, predicting roles in glucagon and somatostatin secretion.\",\n      \"evidence\": \"Oocyte electrophysiology with SNARE coexpression, immunohistochemistry of pancreatic islets\",\n      \"pmids\": [\"16754785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct functional consequence of syntaxin 1A interaction on Kv2.2 gating in native cells not shown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Localization of Kv2.2 to the axon initial segment of MNTB auditory neurons and to axonal processes in Xenopus cultured neurons established its subcellular compartmentalization, with modeling showing it aids Nav channel recovery during high-frequency firing.\",\n      \"evidence\": \"Immunofluorescence with KO-validated antibodies, Hodgkin-Huxley modeling, confocal imaging\",\n      \"pmids\": [\"18511484\", \"18680201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether axonal targeting signals reside in Kv2.2 sequence elements was not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"shRNA knockdown of Kv2.2 in islets selectively enhanced somatostatin but not insulin secretion, while a parallel study showed Kv2.2 physically interacts with Kv2.1 in beta cells to negatively regulate total Kv current and GSIS, delineating cell-type-specific roles for the two Kv2 paralogs in islet hormone secretion.\",\n      \"evidence\": \"Adenovirus-shRNA knockdown, Kv2.1 KO islets with guangxitoxin-1E, co-immunoprecipitation, rescue experiments\",\n      \"pmids\": [\"23161216\", \"23788641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Kv2.1/Kv2.2 heteromers in native beta cells undetermined\", \"Whether Kv2.2 forms homomeric channels in delta cells versus heteromers not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Kv2.2 knockout mice demonstrated two major physiological roles: in auditory brainstem neurons, loss of Kv2.2 broadened APs and impaired high-frequency firing, increasing susceptibility to noise-induced hearing loss; in basal forebrain GABAergic neurons, loss prolonged consolidated wakefulness and reduced NREM delta power, establishing Kv2.2 in sleep–wake regulation.\",\n      \"evidence\": \"Kv2.2 KO mice with viral dominant-negative, ABR recordings, EEG/EMG sleep analysis, c-Fos immunostaining\",\n      \"pmids\": [\"23699522\", \"24293758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory upregulation of other channels in KO not assessed\", \"Circuit-level mechanism linking BF GABAergic activity to wake consolidation not delineated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of KCNB2 as a direct target of miR-1 in atrial tachypacing-induced remodeling showed that miR-1-mediated downregulation of Kv2.2 shortens the atrial effective refractory period and increases IKs, linking the channel to atrial fibrillation substrate.\",\n      \"evidence\": \"Luciferase reporter assay, siRNA knockdown, lentiviral miR-1 overexpression, rabbit tachypacing model, patch clamp\",\n      \"pmids\": [\"24386485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Kv2.2 restoration prevents AF in vivo not tested\", \"Relative contribution of Kv2.2 versus other miR-1 targets to AERP shortening unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapping PKC phosphorylation sites to S481 and S488 on Kv2.2 showed that phosphorylation inhibits channel current and shifts activation, reducing firing frequency in cortical pyramidal neurons — the first direct phosphosite identification for Kv2.2 regulation of cortical excitability.\",\n      \"evidence\": \"Point mutagenesis, phospho-specific antibodies, patch clamp in HEK293 cells and acute cortical slices\",\n      \"pmids\": [\"34542799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream activators of PKC targeting Kv2.2 in cortex not identified\", \"Whether S481/S488 phosphorylation is constitutive or stimulus-dependent in vivo unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that EZH2-mediated H3K27me3 silences KCNB2 at its promoter in obstructed bladder smooth muscle placed Kv2.2 under epigenetic control and showed that EZH2 inhibition restores Kv2.2 expression, linking channel repression to smooth muscle pathology.\",\n      \"evidence\": \"ChIP-PCR for H3K27me3 at KCNB2 promoter, EZH2 inhibitor, siRNA knockdown, Western blot\",\n      \"pmids\": [\"37645613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether H3K27me3-mediated regulation of Kv2.2 occurs in other tissues not explored\", \"Functional electrophysiological consequence in bladder smooth muscle not recorded\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Glucocorticoids rapidly activate Kv2.2 via membrane-associated glucocorticoid receptors and ERK1/2 signaling (non-genomic), increasing single-channel open probability and suppressing neuronal firing, revealing a stress-hormone pathway that tunes Kv2.2 activity within seconds.\",\n      \"evidence\": \"Single-channel recording, membrane-impermeable BSA-dexamethasone, ERK inhibitor U0126, cortical and brainstem slices\",\n      \"pmids\": [\"38075025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation site(s) mediating ERK1/2 activation of Kv2.2 not mapped\", \"Whether this pathway operates in non-neuronal tissues unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PGE2 was shown to inhibit Kv2.2 through EP2/4-PKA-dependent phosphorylation at S448, suppressing beta-cell firing and GSIS; Kcnb2 KO mice were resistant to PGE2-induced glucose intolerance, establishing the complete receptor-to-channel signaling axis for prostaglandin-mediated insulin secretion impairment.\",\n      \"evidence\": \"S448 point mutagenesis, EP receptor agonists/antagonists, Kcnb2 KO mice, glucose tolerance tests, islet perifusion, patch clamp\",\n      \"pmids\": [\"40028769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S448 phosphorylation intersects with PKC-mediated S481/S488 phosphorylation not tested\", \"Role of Kv2.2 in inflammatory settings where PGE2 is elevated not examined in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the high-resolution structure of Kv2.2, the full phosphorylation landscape integrating PKA, PKC, and ERK inputs, the stoichiometry and functional properties of native Kv2.1/Kv2.2 and Kv2.2/Kv6.4 heteromers, and the mechanisms governing Kv2.2's axonal versus somatic targeting in different neuronal populations.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of Kv2.2 available\", \"Phosphosite cross-talk between PKA, PKC, and ERK not mapped\", \"Native heteromer stoichiometry unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 2, 5, 9, 14, 17, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 5, 6, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 5, 9, 12, 14, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 14, 17, 18]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 5, 9, 14, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KCNB1\",\n      \"KCNAB3\",\n      \"STX1A\",\n      \"KCNG4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}